Search General Info
Search Education
Search Partnering Companies

Mahesh Karande

Cambridge, Massachusetts, United States
Mahesh Karande, President and CEO of Omega Therapeutics, is deeply experienced in running biopharma businesses across discovery, preclinical development, clinical development, commercialization and product life cycle management stages. He has been involved with more than 10 product launches in the U.S. and across global markets.

He has strong leadership, operational and business-building experiences combined with a global work history spanning the U.S., Europe, Asia and Africa.

Previously, Mr. Karande was president and CEO of Macrolide Pharmaceuticals from discovery into early development. Earlier, Mr. Karande spent several years at Novartis, leading various U.S. and international business units, including heading the US Oncology Solid Tumors businesses. Mr. Karande left Novartis to join Intarcia Therapeutics as VP and general manager to lead the launch of its first product — a role he left to take the helm at Macrolide.

Mr. Karande has an M.B.A. from the Wharton School, University of Pennsylvania. He is also a graduate of the Georgia Institute of Technology.
Speaking In
[Available On-Demand]
Omega Therapeutics is a preclinical stage genomics medicine enterprise that is transforming…